Cogent Biosciences (COGT) Revenue (2017 - 2020)
Cogent Biosciences (COGT) posted quarterly Revenue of $312000.0 for Q3 2020, down 69.41% year-over-year from $1.0 million in Q4 2019, and down 40.91% quarter-over-quarter from $528000.0 in Q2 2020.
Powered by 
Analysis
Cogent Biosciences (COGT) Revenue (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has reported Revenue for 4 consecutive years, with $312000.0 the latest figure, recorded in Q3 2020.
- In Q3 2020, Revenue fell 69.41% year-over-year to $312000.0; the TTM figure through Dec 2020 stood at $7.9 million (down 65.02% YoY), while the FY2020 annual figure was $7.9 million, down 65.02% from the prior year.
- Revenue retreated to $312000.0 in Q3 2020 per COGT's latest filing, from $528000.0 in the prior quarter.
- Across five years, Revenue topped out at $15.3 million in Q4 2019 and bottomed at $312000.0 in Q3 2020.
- Historically, Revenue has averaged $3.2 million across 4 years, with a median of $2.1 million in 2017.
- Annual changes were most pronounced in 2019 — Revenue soared 301.79% — and 2020, when it slumped 83.17%.
- Cogent Biosciences' Revenue stood at $2.1 million in 2017, then jumped by 79.23% to $3.8 million in 2018, then jumped by 301.79% to $15.3 million in 2019, then slumped by 97.96% to $312000.0 in 2020.
- Business Quant data shows COGT's Revenue at $312000.0 in Q3 2020, $528000.0 in Q2 2020, and $7.0 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Cogent Biosciences | 5.94 Bn | 5.94 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 312,000.00 |
| Jun 30, 2020 | 528,000.00 |
| Mar 31, 2020 | 7.03 Mn |
| Dec 31, 2019 | 15.29 Mn |
| Sep 30, 2019 | 1.02 Mn |
| Jun 30, 2019 | 3.14 Mn |
| Mar 31, 2019 | 3.05 Mn |
| Dec 31, 2018 | 3.81 Mn |
| Sep 30, 2018 | 2.04 Mn |
| Jun 30, 2018 | 1.67 Mn |
| Mar 31, 2018 | 2.22 Mn |
| Dec 31, 2017 | 2.12 Mn |
| Sep 30, 2017 | 2.33 Mn |
| Jun 30, 2017 | 2.08 Mn |
| Mar 31, 2017 | 1.83 Mn |